Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

INRange computerized pill box

This article was originally published in The Gray Sheet

Executive Summary

FDA grants de novo 510(k) clearance June 21 to INRange Systems' Electronic Medication Management Assistant (EMMA), a programmable device that stores and dispenses prescription medications for in-home use. EMMA uses a Web-based application to allow physicians to remotely schedule medications and alter individual doses. The device emits an audible alert when the pills are scheduled to be taken and releases them onto a delivery tray. Health care professionals are provided with a history showing when the patient has accessed the medication. Each EMMA unit holds a month's supply of up to 10 prescriptions. The firm plans to start pilot programs with a number of organizations this year and expects the device will be available for commercial use by early 2008...

You may also be interested in...



Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024946

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel